The Center of Excellence in 3D bioprinting of Cellink at the Indian Institute of Science (IISc), Bengaluru is expected to advance regenerative medicine, tissue engineering and drug discovery. The operations of the facility have commenced after...
In an effort to improve maternal and child health and to spread awareness and provide equitable and widely accessible healthcare services to eventually eradicate anaemia, the Gurugram District Administration and Deloitte announced the...
Buyout firms Advent International, Baring Private Equity Asia (now owned by EQT), Bain Capital, Blackstone, Carlyle and KKR are among those who have been approached to buy the Fosun-owned Gland Pharma, in what would be one of the largest pharma...
Entod Pharmaceuticals has announced that the company is all set to launch its GLO division to further expand its business. This one-of-a-kind ophthalmic subspeciality division is focused on the treatment of the eye condition glaucoma, which is a lead
The US FDA India office has in principle agreed to the Karnataka drugs control department’s request for ‘observer’ role during the plant audits by the US FDA inspectors. The role as an observer would benefit making the audits more effective. Going fo
How is data analytics transforming the biotechnology field and what are the numerous uses & applications of data analytics in biotechnology.
British drug company GlaxoSmithKline (GSK) is betting on power brands, innovative launches in adult vaccines, and a strong recovery in pediatric immunization, to grow double-digit in its key emerging market, India...
The novel CRISPR gene-editing technology has brought on the table a new potential to edit and genetic mutation at will to cure a range of gene related diseases. Here few examples of gene-editing technologies.
Takeda announced that the European Commission granted marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue in individuals from four years of age...
The World Health Organization (WHO) is considering establishing a multi-country regulatory cooperation platform for traditional medicine practitioners, which would speed up global acceptance and accessibility of Ayurveda within 10 to 15 years...